Search Results Search Sort by RelevanceMost Recent State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411. Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411. Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004;6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411. Viewpoint Nov 2004 Ethics, Education, and Integrative Medicine Victoria Maizes, MD and Randy Horwitz, MD, PhD Physician knowledge of complementary and alternative medicine can help patients make informed decisions regarding treatment plans. Virtual Mentor. 2004;6(11):515-517. doi: 10.1001/virtualmentor.2004.6.11.oped1-0411. Policy Forum Nov 2004 Genetic Samples and Genetic Philanthropy Michael E. Berens, PhD and Gary E. Marchant, PhD, JD Genetic research is threatened by lack of samples, and public policy should be developed to encourage public participation. Virtual Mentor. 2004;6(11):509-511. doi: 10.1001/virtualmentor.2004.6.11.pfor2-0411. State of the Art and Science Mar 2003 Diagnosing Alcohol Abuse and Treating Withdrawal Syndrome Audiey Kao, MD, PhD Methods for diagnosing alcohol abuse among medical residents and treating alcohol withdrawal syndrome. Virtual Mentor. 2003;5(3):91-93. doi: 10.1001/virtualmentor.2003.5.3.cprl1-0303. In the Literature May 2003 HIV Policy: Does Most Effective Equal Best? Susanna Smith Public health policies must not only demonstrate a concern for the general public but also respect individual patient privacy and confidentiality. Virtual Mentor. 2003;5(5):174-177. doi: 10.1001/virtualmentor.2003.5.5.jdsc2-0305. Case and Commentary May 2003 Responding to a Request for Early Delivery, Commentary 1 Wendy Savage, MD An elective cesarean section before a fetus is full-term involves various risk factors and should not be done for convenience or emotional reasons. Virtual Mentor. 2003;5(5):159-161. doi: 10.1001/virtualmentor.2003.5.5.ccas2-0305. Case and Commentary May 2003 Responding to a Request for Early Delivery, Commentary 2 Mary Briody Mahowald, PhD An elective cesarean section before a fetus is full-term involves various risk factors and should not be done for convenience or emotional reasons. Virtual Mentor. 2003;5(5):162-164. doi: 10.1001/virtualmentor.2003.5.5.ccas2-0305. State of the Art and Science May 2003 Reducing HIV Transmission from Mother to Infant Audiey Kao, MD, PhD An HIV-positive expectant mother can deliver an HIV-negative baby with proper planning and treatment. Virtual Mentor. 2003;5(5):183-185. doi: 10.1001/virtualmentor.2003.5.5.cprl2-0305. Pagination First page « First Previous page ‹ Previous … Page 79 Page 80 Page 81 Page 82 Page 83 Page 84 Page 85 Current page 86 Page 87 Next page Next › Last page Last »
State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411.
Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411.
Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004;6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411.
Viewpoint Nov 2004 Ethics, Education, and Integrative Medicine Victoria Maizes, MD and Randy Horwitz, MD, PhD Physician knowledge of complementary and alternative medicine can help patients make informed decisions regarding treatment plans. Virtual Mentor. 2004;6(11):515-517. doi: 10.1001/virtualmentor.2004.6.11.oped1-0411.
Policy Forum Nov 2004 Genetic Samples and Genetic Philanthropy Michael E. Berens, PhD and Gary E. Marchant, PhD, JD Genetic research is threatened by lack of samples, and public policy should be developed to encourage public participation. Virtual Mentor. 2004;6(11):509-511. doi: 10.1001/virtualmentor.2004.6.11.pfor2-0411.
State of the Art and Science Mar 2003 Diagnosing Alcohol Abuse and Treating Withdrawal Syndrome Audiey Kao, MD, PhD Methods for diagnosing alcohol abuse among medical residents and treating alcohol withdrawal syndrome. Virtual Mentor. 2003;5(3):91-93. doi: 10.1001/virtualmentor.2003.5.3.cprl1-0303.
In the Literature May 2003 HIV Policy: Does Most Effective Equal Best? Susanna Smith Public health policies must not only demonstrate a concern for the general public but also respect individual patient privacy and confidentiality. Virtual Mentor. 2003;5(5):174-177. doi: 10.1001/virtualmentor.2003.5.5.jdsc2-0305.
Case and Commentary May 2003 Responding to a Request for Early Delivery, Commentary 1 Wendy Savage, MD An elective cesarean section before a fetus is full-term involves various risk factors and should not be done for convenience or emotional reasons. Virtual Mentor. 2003;5(5):159-161. doi: 10.1001/virtualmentor.2003.5.5.ccas2-0305.
Case and Commentary May 2003 Responding to a Request for Early Delivery, Commentary 2 Mary Briody Mahowald, PhD An elective cesarean section before a fetus is full-term involves various risk factors and should not be done for convenience or emotional reasons. Virtual Mentor. 2003;5(5):162-164. doi: 10.1001/virtualmentor.2003.5.5.ccas2-0305.
State of the Art and Science May 2003 Reducing HIV Transmission from Mother to Infant Audiey Kao, MD, PhD An HIV-positive expectant mother can deliver an HIV-negative baby with proper planning and treatment. Virtual Mentor. 2003;5(5):183-185. doi: 10.1001/virtualmentor.2003.5.5.cprl2-0305.